DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food ...

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and ...

Glucotrack, Inc. announced that it will present safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system at the 2025 International ...

Through this collaboration, Glucotrack will leverage next-generation artificial intelligence and machine learning-based analytics to evaluate clinical study data from its Continuous Blood Glucose ...

In a study, published in CHEST Critical Care, University of Michigan researchers show that using continuous glucose monitors can help measure glucose accurately during DKA and potentially prevent ...

The letter also noted that the company does not monitor how acetaminophen affects glucose sensing with its G7 monitors. The FDA also said Dexcom is not properly evaluating the risk of using the G6 ...

The 15.5-day Dexcom G7 continuous glucose monitor (CGM) demonstrated high accuracy and safety in adults with diabetes, meeting and exceeding integrated CGM performance goals.